DK1385898T3 - Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser - Google Patents

Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser

Info

Publication number
DK1385898T3
DK1385898T3 DK02734076T DK02734076T DK1385898T3 DK 1385898 T3 DK1385898 T3 DK 1385898T3 DK 02734076 T DK02734076 T DK 02734076T DK 02734076 T DK02734076 T DK 02734076T DK 1385898 T3 DK1385898 T3 DK 1385898T3
Authority
DK
Denmark
Prior art keywords
poly
formic acid
reduced amounts
pharmaceutical composition
polymers
Prior art date
Application number
DK02734076T
Other languages
English (en)
Inventor
You-Ling Fan
Original Assignee
Union Carbide Chem Plastic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Chem Plastic filed Critical Union Carbide Chem Plastic
Application granted granted Critical
Publication of DK1385898T3 publication Critical patent/DK1385898T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
DK02734076T 2001-05-01 2002-04-29 Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser DK1385898T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28788501P 2001-05-01 2001-05-01

Publications (1)

Publication Number Publication Date
DK1385898T3 true DK1385898T3 (da) 2006-10-02

Family

ID=23104789

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02734076T DK1385898T3 (da) 2001-05-01 2002-04-29 Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser

Country Status (8)

Country Link
EP (1) EP1385898B1 (da)
JP (1) JP4481569B2 (da)
AT (1) ATE328028T1 (da)
DE (1) DE60211885T2 (da)
DK (1) DK1385898T3 (da)
ES (1) ES2260437T3 (da)
IL (2) IL158620A0 (da)
WO (1) WO2002088217A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1503732B1 (en) * 2002-04-29 2008-10-08 Alza Corporation Reduced formate poly(alkylene oxides) with reboxetine for reducing impurity formation
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2548151A1 (en) * 2005-06-02 2006-12-02 Nippon Shokubai Co., Ltd. Process for manufacturing a pellet-shaped nonionic alkylene oxide resin
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko) 2008-01-25 2016-05-02 그뤼넨탈 게엠베하 약제학적 투여형
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
MX2012000317A (es) 2009-07-22 2012-02-08 Gruenenthal Gmbh Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
ES2487244T3 (es) 2010-09-02 2014-08-20 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende un polímero aniónico
AU2012292418B2 (en) 2011-07-29 2017-02-16 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
CN104394851B (zh) 2012-04-18 2017-12-01 格吕伦塔尔有限公司 抗篡改和抗剂量‑倾泻药物剂型
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
CN113945535B (zh) * 2021-12-20 2022-03-29 浙江湃肽生物有限公司南京分公司 用于测量醋酸戈舍瑞林缓释植入剂体外溶出度的方法
CN117538462B (zh) * 2024-01-10 2024-03-26 地奥集团成都药业股份有限公司 一种氨氯地平贝那普利胶囊有关物质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108011C (da) * 1957-06-27
US3167519A (en) * 1958-12-29 1965-01-26 Union Carbide Corp Polymerization of epoxides
US5216122A (en) * 1991-05-21 1993-06-01 Union Carbide Chemicals & Plastics Technology Corporation Removal of residual ethylene oxide from poly(ethylene oxide)
SE9902364D0 (sv) * 1999-06-21 1999-06-21 Astra Ab New process

Also Published As

Publication number Publication date
JP4481569B2 (ja) 2010-06-16
DE60211885D1 (de) 2006-07-06
IL158620A (en) 2010-06-30
WO2002088217A1 (en) 2002-11-07
DE60211885T2 (de) 2006-11-02
IL158620A0 (en) 2004-05-12
ATE328028T1 (de) 2006-06-15
JP2004530748A (ja) 2004-10-07
EP1385898A1 (en) 2004-02-04
ES2260437T3 (es) 2006-11-01
EP1385898B1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
DK1385898T3 (da) Farmaceutisk sammensætning omfattende poly(alkylenoxider) med reducerede mængder af myresyreforbindelser
MXPA03008886A (es) Composiciones de baja respuesta glicemica.
MXPA03009571A (es) Metodo para tratar la gota y unir el acido urico.
RS52731B (sr) Farmaceutska kompozicija za upotrebu u lečenju ateroskleroze, dislipidemija i sa njima povezanih stanja
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
TW200632554A (en) Photoresist composition for deep UV and process thereof
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
WO2002100860A3 (fr) Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
TW200700923A (en) Antireflective hardmask composition and methods for using same
MXPA05002476A (es) Asialo-interferones modificados y sus usos.
TW200634181A (en) Electroplating composition and method
TW200643622A (en) Antireflective hardmask composition and methods for using same
WO2005007115A3 (en) Pharmaceutical composition for inhibiting acid secretion
WO2007080071A3 (de) Dentalabformmassen und daraus hergestellte gehärtete produkte
PL1843749T3 (pl) Kompozycje o kontrolowanym uwalnianiu dla interferonu na bazie kopolimerów blokowych PEGT/PBT
NO20053089D0 (no) Carbamidsyreestere med anticolinergisk virkning.
CY1105847T1 (el) Γραμμικες βασικες ενωσεις που εμφανιζουν δραστικοτητα ανταγωνιστη της nk-2 και σκευασματα αυτων
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
BRPI0517150A (pt) composição polimérica tendo propriedades de extrusão de fundido melhoradas
WO2002067865A3 (en) N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
DK1656418T3 (da) Stabiliseringssystem for halogenholdige polymerer
ATE420918T1 (de) Sauerstoffbarriereformulierungen
BRPI0406100A (pt) álcoois terciários insaturados como ligantes para catalisadores dmc
WO2004076474A3 (en) Polyethylene glycol modified interferon compositions and methods of use thereof
DK1124546T3 (da) Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis